Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Syntara.
RELATED STOCKHEAD STORIES
News
10 at 10: These ASX stocks are leading the rally this morning
Experts
Scopo’s Health Powerplays: Show me the (grant) money
News
Trading Places: Cybersecurity stocks are in hot demand by fund managers
Health & Biotech
Check up: A good fortnight to be a small cap health investor
Experts
Scopo’s health powerplays: quick vaccine hits and cheap buys
Health & Biotech
Pharmaxis forges ahead with phase 2 cancer drug trial in spite of COVID-19
Health & Biotech
Dr Boreham’s Crucible: Why CSL is the poster child for most junior drug developers
News
Weekly ASX small cap wrap: Who got a bit too silly in the silly season this week?
News
Lunchtime ASX small cap wrap: Who’s taking an early break today?
Health & Biotech
Health: Pharmaxis partner quits NASH drug development, shares halve
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health: Is this the big news from Germany Pharmaxis was waiting for?
Experts
On the Radar: 5 small caps that brokers pick for growth in the months ahead
Health & Biotech
The health sector has been the ASX’s top performer in 2019, but could a recession stop it in its tracks?
Health & Biotech
These are the 22 small cap biotechs closest to bringing a drug to market
Health & Biotech
Health: Resonance Health says cash receipts continue to grow, but investors are looking for more
Health & Biotech
